| Last visit was: 01 May 2026, 18:29 |
It is currently 01 May 2026, 18:29 |
|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Denied without Interview
|
Early Action | 2025 | 695 GMAT Focus 660 GMAT Classic |
3.2 | 4 | Consulting | India |
13 Jan 2025 04:25 PM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 335 GRE | 3.6 | 3 | Consulting | China |
13 Jan 2025 09:58 AM
|
| Full Time MBA |
Waitlisted without Interview
|
Round 1 | 2025 | 710 GMAT Classic | 9.7 | 3 | Healthcare/Pharmaceuticals | India |
09 Jan 2025 03:57 PM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2025 | 690 GMAT Classic 720 GMAT Classic |
3 | 5 | Consumer Packaged Goods | United States |
09 Jan 2025 11:50 AM
|
| Full Time MBA |
Withdrawn Application
|
Round 1 | 2025 | 165 EA | 5 | Finance: Investment Banking | Brazil |
23 Dec 2024 09:23 AM
|
|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2025 | 765 GMAT Focus | 8 | 6 | Technology | India |
23 Dec 2024 02:22 AM
|
| Full Time MBA |
Admitted, ($$$)
|
Round 1 | 2025 | 700 GMAT Classic | 3.7 | 6 | Finance: Venture Capital | Israel |
22 Dec 2024 02:49 AM
|
| Full Time MBA |
Admitted, ($)
|
Round 1 | 2025 | 157 EA | 3.5 | 8 | Finance: Investment Banking | Brazil |
17 Dec 2024 09:18 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2025 | 715 GMAT Focus | 4 | Healthcare/Pharmaceuticals | India |
16 Dec 2024 01:17 PM
|
|
| Full Time MBA |
Denied with Interview
|
Round 1 | 2025 | 715 GMAT Focus | 8.5 | 5 | Consulting | India |
16 Dec 2024 02:37 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2025 | 740 GMAT Classic | 8.7 | 4 | Healthcare/Pharmaceuticals | India |
14 Dec 2024 06:46 AM
|
| Full Time MBA |
Admitted
|
Round 1 | 2025 | 625 GMAT Focus 650 GMAT Classic |
3 | Healthcare/Pharmaceuticals | India |
13 Dec 2024 10:24 PM
|
|
| Full Time MBA |
Admitted
|
Round 1 | 2025 | 655 GMAT Focus | 3.7 | 8 | Pharmaceuticals and Biotech | Korea, Republic of |
13 Dec 2024 10:09 PM
|
| Full Time MBA |
Admitted, ($$)
|
Round 1 | 2025 | 655 GMAT Focus | 3 | 6 | Consumer Packaged Goods | Viet Nam |
13 Dec 2024 09:37 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2025 | 4.6 | 6 | Consulting | Nigeria |
13 Dec 2024 12:04 AM
|
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 645 GMAT Focus | 3.5 | 4 | Consulting | Pakistan |
12 Dec 2024 11:44 PM
|
| Full Time MBA |
Waitlisted without Interview
|
Round 1 | 2025 | 4 | Technology | India |
12 Dec 2024 09:33 PM
|
||
| Full Time MBA |
Admitted, ($$)
|
Round 1 | 2025 | 695 GMAT Focus | 8.7 | 5 | Consulting | India |
12 Dec 2024 09:16 PM
|
| Full Time MBA |
Waitlisted without Interview
|
Round 1 | 2025 | 695 GMAT Focus 680 GMAT Classic |
8 | 6 | Consulting | India |
12 Dec 2024 08:31 PM
|
| Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 705 GMAT Focus | 3.7 | 3 | Technology | India |
12 Dec 2024 08:25 PM
|